Organ-specific features of natural killer cells

[1]  A. Moffett,et al.  How does variability of immune system genes affect placentation? , 2011, Placenta.

[2]  J. Renauld,et al.  Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt− lymphoid cells , 2011, The EMBO journal.

[3]  R. Ransohoff,et al.  Analyses of phenotypic and functional characteristics of CX3CR1‐expressing natural killer cells , 2011, Immunology.

[4]  F. Shi,et al.  Interleukin‐2/interleukin‐2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation , 2011, Annals of neurology.

[5]  Z. Redzic Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences , 2011, Fluids and Barriers of the CNS.

[6]  H. Ljunggren,et al.  Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus , 2011, The Journal of experimental medicine.

[7]  M. Caligiuri,et al.  Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.

[8]  U. Pannicke,et al.  Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. , 2010, Immunity.

[9]  H. Ljunggren,et al.  Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. , 2010, Blood.

[10]  Jessica A. Randall,et al.  Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high‐risk individuals and inhibits replication in vitro , 2010, Hepatology.

[11]  M. Carrington,et al.  Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. , 2010, The Journal of clinical investigation.

[12]  M. Caligiuri,et al.  Immature NK Cells, Capable of Producing IL-22, Are Present in Human Uterine Mucosa , 2010, The Journal of Immunology.

[13]  P. Brodin,et al.  Current perspectives of natural killer cell education by MHC class I molecules , 2010, Nature Reviews Immunology.

[14]  O. Griesbeck,et al.  In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. , 2010, Immunity.

[15]  F. Shi,et al.  Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathology , 2010, The Journal of experimental medicine.

[16]  Richard A. Flavell,et al.  The polarization of immune cells in the tumour environment by TGFβ , 2010, Nature Reviews Immunology.

[17]  W. Mehal,et al.  Cell death and fibrogenesis. , 2010, Seminars in liver disease.

[18]  B. Badie,et al.  Induction of Anti-Glioma Natural Killer Cell Response following Multiple Low-Dose Intracerebral CpG Therapy , 2010, Clinical Cancer Research.

[19]  Vasilis Toxavidis,et al.  In vivo tracking of 'color-coded' effector, natural and induced regulatory T cells in the allograft response , 2010, Nature Medicine.

[20]  D. Topham,et al.  Interleukin-22 (IL-22) Production by Pulmonary Natural Killer Cells and the Potential Role of IL-22 during Primary Influenza Virus Infection , 2010, Journal of Virology.

[21]  W. Yokoyama,et al.  Memory‐like responses of natural killer cells , 2010, Immunological reviews.

[22]  A. Sher,et al.  Redundant and Pathogenic Roles for IL-22 in Mycobacterial, Protozoan, and Helminth Infections , 2010, The Journal of Immunology.

[23]  Jeffrey A. Bluestone,et al.  Genetics, pathogenesis and clinical interventions in type 1 diabetes , 2010, Nature.

[24]  J. Lambris,et al.  Crosstalk pathways between Toll-like receptors and the complement system. , 2010, Trends in immunology.

[25]  Eric O Long,et al.  Regulation of human NK-cell cytokine and chemokine production by target cell recognition. , 2010, Blood.

[26]  D. Holmberg,et al.  Distinct Phenotype and Function of NK Cells in the Pancreas of Nonobese Diabetic Mice , 2010, The Journal of Immunology.

[27]  Michael G Brown,et al.  Intrahepatic IL-10 Maintains NKG2A+Ly49− Liver NK Cells in a Functionally Hyporesponsive State , 2010, The Journal of Immunology.

[28]  Y. Dor,et al.  The activating receptor NKp46 is essential for the development of type 1 diabetes , 2010, Nature Immunology.

[29]  Maria T. Abreu,et al.  Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function , 2010, Nature Reviews Immunology.

[30]  F. Shi,et al.  Nature killer cells in the central nervous system , 2010, Natural Killer Cells.

[31]  Jianzhu Chen,et al.  Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice , 2009, Proceedings of the National Academy of Sciences.

[32]  F. Shi,et al.  Natural killer cells in human autoimmunity. , 2009, Current opinion in immunology.

[33]  H. Wekerle,et al.  Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions , 2009, Nature.

[34]  M. Deckert,et al.  Comment on “Critical Roles of NK and CD8+ T Cells in Central Nervous System Listeriosis” , 2009, The Journal of Immunology.

[35]  D. Bourdette,et al.  Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis , 2009, Journal of Neuroimmunology.

[36]  C. Benoist,et al.  How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. , 2009, Immunity.

[37]  D. Raulet,et al.  Oncogenic stress sensed by the immune system: role of natural killer cell receptors , 2009, Nature Reviews Immunology.

[38]  W. Robinson,et al.  Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis , 2009, Proceedings of the National Academy of Sciences.

[39]  T. Waldmann,et al.  Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis. , 2009, Archives of neurology.

[40]  F. Takei,et al.  NK cell development from a novel progenitor found in the murine lung (138.10) , 2009, The Journal of Immunology.

[41]  R. Sun,et al.  TLR-9 Activation Aggravates Concanavalin A-Induced Hepatitis via Promoting Accumulation and Activation of Liver CD4+ NKT Cells1 , 2009, The Journal of Immunology.

[42]  J. Rolin,et al.  Modulation of natural killer cell cytotoxicity and cytokine release by the drug glatiramer acetate , 2009, Cellular and Molecular Life Sciences.

[43]  Liping Yang,et al.  Cytokine-induced memory-like natural killer cells , 2009, Proceedings of the National Academy of Sciences.

[44]  Joseph C. Sun,et al.  Adaptive Immune Features of Natural Killer Cells , 2009, Nature.

[45]  P. Bouteiller Faculty Opinions recommendation of Unique receptor repertoire in mouse uterine NK cells. , 2009 .

[46]  J. Lünemann,et al.  Human NK Cells Kill Resting but Not Activated Microglia via NKG2D- and NKp46-Mediated Recognition1 , 2008, The Journal of Immunology.

[47]  S. Momohara,et al.  Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients , 2008, The FEBS journal.

[48]  R. Apps,et al.  Killer Ig-Like Receptor Expression in Uterine NK Cells Is Biased toward Recognition of HLA-C and Alters with Gestational Age1 , 2008, The Journal of Immunology.

[49]  T. Strowig,et al.  Noncytotoxic Functions of NK Cells: Direct Pathogen Restriction and Assistance to Adaptive Immunity1 , 2008, The Journal of Immunology.

[50]  D. Heinrichs,et al.  NK Cells Play a Critical Protective Role in Host Defense against Acute Extracellular Staphylococcus aureus Bacterial Infection in the Lung1 , 2008, The Journal of Immunology.

[51]  L. Lanier Evolutionary struggles between NK cells and viruses , 2008, Nature Reviews Immunology.

[52]  R. Planas,et al.  Natural killer cells are required for accelerated type 1 diabetes driven by interferon‐β , 2008, Clinical and experimental immunology.

[53]  Sugata Roy,et al.  NK Cells Lyse T Regulatory Cells That Expand in Response to an Intracellular Pathogen1 , 2008, The Journal of Immunology.

[54]  R. Pierce,et al.  TLR-dependent cross talk between human Kupffer cells and NK cells , 2008, The Journal of experimental medicine.

[55]  Yannick Jacques,et al.  Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor , 2007, Nature Immunology.

[56]  H. Neumann,et al.  Neuronal ‘On’ and ‘Off’ signals control microglia , 2007, Trends in Neurosciences.

[57]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[58]  L. Klareskog,et al.  Natural killer cells trigger differentiation of monocytes into dendritic cells. , 2007, Blood.

[59]  N. Huntington,et al.  Developmental pathways that generate natural-killer-cell diversity in mice and humans , 2007, Nature Reviews Immunology.

[60]  J. Rose,et al.  Daclizumab phase II trial in relapsing and remitting multiple sclerosis , 2007, Neurology.

[61]  J. Carulli,et al.  Inflammatory arthritis can be reined in by CpG-induced DC–NK cell cross talk , 2007, The Journal of experimental medicine.

[62]  D. Patel,et al.  Defective antitumor responses in CX3CR1‐deficient mice , 2007, International journal of cancer.

[63]  T. Enver,et al.  CD56bright Human NK Cells Differentiate into CD56dim Cells: Role of Contact with Peripheral Fibroblasts , 2007, The Journal of Immunology.

[64]  A. Thiel,et al.  CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation1 , 2007, The Journal of Immunology.

[65]  C. Farina,et al.  Astrocytes are active players in cerebral innate immunity. , 2007, Trends in immunology.

[66]  D. Keskin,et al.  TGFβ promotes conversion of CD16+ peripheral blood NK cells into CD16− NK cells with similarities to decidual NK cells , 2007, Proceedings of the National Academy of Sciences.

[67]  W. Kuziel,et al.  Susceptibility of CCR5-Deficient Mice to Genital Herpes Simplex Virus Type 2 Is Linked to NK Cell Mobilization , 2007, Journal of Virology.

[68]  F. Tacke,et al.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. , 2007, The Journal of clinical investigation.

[69]  E. Ponomarev,et al.  GM-CSF Production by Autoreactive T Cells Is Required for the Activation of Microglial Cells and the Onset of Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.

[70]  N. Hayashi,et al.  Natural killer cell and hepatic cell interaction via NKG2A leads to dendritic cell‐mediated induction of CD4+ CD25+ T cells with PD‐1‐dependent regulatory activities , 2007, Immunology.

[71]  C. Schaumburg,et al.  T Cell Antiviral Effector Function Is Not Dependent on CXCL10 Following Murine Coronavirus Infection1 , 2006, The Journal of Immunology.

[72]  C. Tayade,et al.  Uterine natural killer cells: a specialized differentiation regulated by ovarian hormones , 2006, Immunological reviews.

[73]  F. Shi,et al.  Reciprocal regulation between natural killer cells and autoreactive T cells , 2006, Nature Reviews Immunology.

[74]  J. Hanna,et al.  Decidual NK cells regulate key developmental processes at the human fetal-maternal interface , 2006, Nature Medicine.

[75]  A. Moffett,et al.  Immunology of placentation in eutherian mammals , 2006, Nature Reviews Immunology.

[76]  S. van der Linden,et al.  The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. , 2006, Arthritis and rheumatism.

[77]  F. Shi,et al.  Autoreactive T Cells Mediate NK Cell Degeneration in Autoimmune Disease1 , 2006, The Journal of Immunology.

[78]  Steffen Jung,et al.  The FASEB Journal • Research Communication The neuronal chemokine CX3CL1/fractalkine , 2022 .

[79]  U. V. Andrian,et al.  T cell– and B cell–independent adaptive immunity mediated by natural killer cells , 2006, Nature Immunology.

[80]  Ido D. Weiss,et al.  IFN-γ Acts on T Cells to Induce NK Cell Mobilization and Accumulation in Target Organs1 , 2006, The Journal of Immunology.

[81]  T. Waldmann,et al.  Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[82]  R. Ransohoff,et al.  Severe Disease, Unaltered Leukocyte Migration, and Reduced IFN-γ Production in CXCR3−/− Mice with Experimental Autoimmune Encephalomyelitis1 , 2006, The Journal of Immunology.

[83]  M. Alsharifi,et al.  NK cell‐mediated immunopathology during an acute viral infection of the CNS , 2006, European journal of immunology.

[84]  E. Sternberg Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens , 2006, Nature Reviews Immunology.

[85]  Lisa M. Ebert,et al.  Homing and Function of Human Skin γδ T Cells and NK Cells: Relevance for Tumor Surveillance , 2006, The Journal of Immunology.

[86]  R. Germain,et al.  Natural killer cell behavior in lymph nodes revealed by static and real-time imaging , 2006, The Journal of experimental medicine.

[87]  M. Smyth,et al.  CD27 Dissects Mature NK Cells into Two Subsets with Distinct Responsiveness and Migratory Capacity1 , 2006, The Journal of Immunology.

[88]  G. Girolomoni,et al.  CD56brightCD16– NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation , 2006, European journal of immunology.

[89]  G. Feldmann,et al.  Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C , 2005, Gut.

[90]  L. Kaer,et al.  NK cells promote islet allograft tolerance via a perforin-dependent mechanism , 2005, Nature Network Boston.

[91]  E. Ponomarev,et al.  Microglial cell activation and proliferation precedes the onset of CNS autoimmunity , 2005, Journal of neuroscience research.

[92]  Jeff F. Miller,et al.  CXCR3 and Its Ligands Participate in the Host Response to Bordetella bronchiseptica Infection of the Mouse Respiratory Tract but Are Not Required for Clearance of Bacteria from the Lung , 2005, Infection and Immunity.

[93]  J. Rose,et al.  Treatment of multiple sclerosis with an anti–interleukin‐2 receptor monoclonal antibody , 2004, Annals of neurology.

[94]  N. Hayashi,et al.  Negative Regulation of NK Cell Activities by Inhibitory Receptor CD94/NKG2A Leads to Altered NK Cell-Induced Modulation of Dendritic Cell Functions in Chronic Hepatitis C Virus Infection1 , 2004, The Journal of Immunology.

[95]  M. Carrington,et al.  Combinations of Maternal KIR and Fetal HLA-C Genes Influence the Risk of Preeclampsia and Reproductive Success , 2004, The Journal of experimental medicine.

[96]  R. Homer,et al.  Regulation of pulmonary fibrosis by chemokine receptor CXCR3. , 2004, The Journal of clinical investigation.

[97]  J. Bluestone,et al.  NKG2D blockade prevents autoimmune diabetes in NOD mice. , 2004, Immunity.

[98]  K. Ley,et al.  Trafficking of natural killer cells. , 2004, Current molecular medicine.

[99]  Christophe Benoist,et al.  Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[100]  P. Masters,et al.  CXC Chemokine Ligand 10 Controls Viral Infection in the Central Nervous System: Evidence for a Role in Innate Immune Response through Recruitment and Activation of Natural Killer Cells , 2004, Journal of Virology.

[101]  R. Tan,et al.  Regulation of Autoimmune Diabetes by Complete Freund’s Adjuvant Is Mediated by NK Cells , 2004, The Journal of Immunology.

[102]  B. Morrison,et al.  Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. , 2003, The Journal of clinical investigation.

[103]  W. Yokoyama,et al.  Natural killer cells and autoimmunity , 2003, Arthritis research & therapy.

[104]  J. Hanna,et al.  CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells. , 2003, Blood.

[105]  S. Khoury,et al.  The Programmed Death-1 (PD-1) Pathway Regulates Autoimmune Diabetes in Nonobese Diabetic (NOD) Mice , 2003, The Journal of experimental medicine.

[106]  L. Moretta,et al.  The interaction between NK cells and dendritic cells in bacterial infections results in rapid induction of NK cell activation and in the lysis of uninfected dendritic cells , 2003, European journal of immunology.

[107]  A. Moffett-King Natural killer cells and pregnancy , 2002, Nature Reviews Immunology.

[108]  L. Joosten,et al.  Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis. , 2002, Arthritis and rheumatism.

[109]  N. Sarvetnick,et al.  Target cell defense prevents the development of diabetes after viral infection , 2002, Nature Immunology.

[110]  T. Martin,et al.  Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis , 2002 .

[111]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[112]  K. Ando,et al.  Enhancement of Human Cord Blood CD34+ Cell-Derived NK Cell Cytotoxicity by Dendritic Cells1 , 2001, The Journal of Immunology.

[113]  J. D. Di Santo,et al.  Interferon γ Contributes to Initiation of Uterine Vascular Modification, Decidual Integrity, and Uterine Natural Killer Cell Maturation during Normal Murine Pregnancy , 2000, The Journal of experimental medicine.

[114]  K. Uhlig,et al.  Predominance of mononuclear cells expressing the chemokine receptor CCR5 in synovial effusions of patients with different forms of arthritis. , 1999, Arthritis and rheumatism.

[115]  J. Orange,et al.  Early Murine Cytomegalovirus (MCMV) Infection Induces Liver Natural Killer (NK) Cell Inflammation and Protection Through Macrophage Inflammatory Protein 1α (MIP-1α)–dependent Pathways , 1998, The Journal of experimental medicine.

[116]  T. Tabira,et al.  Regulation of Experimental Autoimmune Encephalomyelitis by Natural Killer (NK) Cells , 1997, The Journal of experimental medicine.

[117]  G. Gerken,et al.  Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge. , 1995, Journal of hepatology.

[118]  F. Breedveld,et al.  Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. , 1994, Arthritis and rheumatism.

[119]  Moses Rodriguez,et al.  Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. , 1989, Journal of immunology.

[120]  K. McIntyre,et al.  Accumulation of natural killer and cytotoxic T large granular lymphocytes in the liver during virus infection , 1986, The Journal of experimental medicine.

[121]  H. Spits,et al.  The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling , 2011, Nature Immunology.

[122]  Y. S. Hahn,et al.  Regulation of NK cell repertoire and function in the liver. , 2011, Critical reviews in immunology.

[123]  A. Telenti,et al.  Critical role for the chemokine receptor CXCR 6 in NK cell – mediated antigen-specific memory of haptens and viruses , 2010 .

[124]  Bradford Z. Mahon,et al.  Category-Specific Organization in the Human Brain Does Not Require Visual Experience , 2009, Neuron.

[125]  W. Kuziel,et al.  Monocyte Chemoattractant Protein-1 and CCR2 Interactions Are Required for IFN- / -Induced Inflammatory Responses and Antiviral Defense in Liver , 2005 .

[126]  P. Bioulac-Sage,et al.  [Mechanisms of hepatic fibrogenesis]. , 2002, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[127]  R. Herberman Natural killer cells. , 1989, Progress in clinical and biological research.

[128]  I. Kimber Natural killer cells. , 1985, Medical laboratory sciences.